Hirono Tsutsumi

机构：Kyushu University, Fukuoka Higashi Medical Center

发表论文 17 篇 · 总被引 154 次 · h-index 7

代表论文

• TP53 gain-of-function mutations promote osimertinib resistance via TNF-α–NF-κB signaling in EGFR-mutated lung cancer (2024 · npj Precision Oncology · 被引 45)
• Cytotoxic chemotherapeutic agents and the EGFR-TKI osimertinib induce calreticulin exposure in non–small cell lung cancer (2021 · Lung Cancer · 被引 26)
• Regulation of PD-L1 expression in non–small cell lung cancer by interleukin-1β (2023 · Frontiers in Immunology · 被引 20)
• Increased plasma levels of damage-associated molecular patterns during systemic anticancer therapy in patients with advanced lung cancer (2021 · Translational Lung Cancer Research · 被引 20)
• Impact of increased plasma levels of calreticulin on prognosis of patients with advanced lung cancer undergoing combination treatment of chemotherapy and immune checkpoint inhibitors (2023 · Lung Cancer · 被引 10)
• IFITM3-MET interaction drives osimertinib resistance through AKT pathway activation in EGFR-mutant non–small cell lung cancer (2025 · Molecular Cancer · 被引 9)